Aprogen Biologics warned of KRX watchlist risk as market cap stays below KRW 30 billion for 25 trading days

Bitget2026/10/06 08:42

KRX flagged Aprogen Biologics for potential “administrative issue” designation tied to market-cap compliance. As of Oct. 6, 2026, its listed common shares stayed below KRW 30 billion market capitalization for 25 trading days. If the shortfall persists for 30 trading days, the stock will be designated an administrative issue under KRX listing rules. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aprogen Biologics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006800649), on October 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.